NR565 MIDTERM PRACTICE EXAM
WITH 100% CORRECT AND VERIFIED
ANSWERS | LATEST UPGRADE 2026
Advanced Pharmacology Fundamentals (Chamberlain University)
, NR565 | Advanced Pharmacology Fundamentals
Midterm Exam — Practice Questions
100 Questions | Weeks 1-4 | ExamSoft Format
Based on: Rosenthal & Burchum — Lehne's Pharmacotherapeutics for Advanced Practice Providers, 3rd ed.
EXAM INSTRUCTIONS
This practice exam mirrors Exam Soft format. Each question is clinical scenario-based with four answer
choices (A-D). Select the BEST answer. Correct answers and rationale are provided below each question for
self- assessment.
Total Questions Time Allotted Format Chapters
100 Questions 120 Minutes Multiple Choice (A-D) 1-10, 36-39, 41-46, 24,
35, 59-63
For educational use only | NR565 Midterm Practice Exam 2026
, WEEK 1 | Chapters 1-10 | Foundations in Pharmacology (Questions 1-
25)
1. [Prescriptive Authority] A nurse practitioner in a state with full practice authority wants to prescribe a
Schedule II controlled substance. Which of the following is required?
A. Collaboration agreement with a supervising physician
B. A valid DEA registration number
C. Approval from the state board of medicine
D. Completion of a pain management fellowship
Correct Answer: B
Rationale: Prescribing Schedule II controlled substances requires a valid DEA registration number
regardless of practice authority level. Full practice authority removes the need for physician collaboration
agreements for non-controlled prescribing.
Reference: Rosenthal, L. D., & Burchum, J. R. (2026). Lehne's pharmacotherapeutics for advanced practice providers
(3rd ed.). Elsevier.
2. [Prescription Writing] When writing a valid outpatient prescription, which element is legally required on
EVERY prescription?
A. Diagnosis code (ICD-10)
B. Patient's date of birth
C. Drug name, dose, route, frequency, and quantity
D. Insurance provider information
Correct Answer: C
Rationale: Every prescription must contain the drug name, dose, route of administration,
frequency/directions (sig), and quantity to dispense. Date of birth is best practice but not universally legally
mandated on the face of the prescription in all states.
Reference: Rosenthal, L. D., & Burchum, J. R. (2026). Lehne's pharmacotherapeutics for advanced practice providers
(3rd ed.). Elsevier.
3. [Drug Absorption] A patient with severe small bowel disease has markedly reduced intestinal surface area.
Which route of drug administration would BEST bypass this limitation?
A. Oral (PO)
B. Sublingual (SL)
C. Rectal (PR)
D. Intravenous (IV)
Correct Answer: D
Rationale: IV administration delivers drug directly into systemic circulation, completely bypassing GI
absorption. This achieves 100% bioavailability and is unaffected by intestinal surface area reductions.
Reference: Rosenthal, L. D., & Burchum, J. R. (2026). Lehne's pharmacotherapeutics for advanced practice providers
(3rd ed.). Elsevier.
4. [Drug Distribution] Which property of a drug MOST directly determines its volume of distribution (Vd)?
A. Renal clearance rate
B. Plasma protein binding and lipid solubility
C. First-pass metabolism
D. CYP enzyme affinity
Correct Answer: B
Rationale: Volume of distribution is determined largely by a drug's lipid solubility (highly lipid-soluble drugs
distribute widely into tissues) and protein binding (highly protein-bound drugs stay in the vascular
compartment, lowering Vd).
Reference: Rosenthal, L. D., & Burchum, J. R. (2026). Lehne's pharmacotherapeutics for advanced practice providers
(3rd ed.). Elsevier.
For educational use only | NR565 Midterm Practice Exam
WITH 100% CORRECT AND VERIFIED
ANSWERS | LATEST UPGRADE 2026
Advanced Pharmacology Fundamentals (Chamberlain University)
, NR565 | Advanced Pharmacology Fundamentals
Midterm Exam — Practice Questions
100 Questions | Weeks 1-4 | ExamSoft Format
Based on: Rosenthal & Burchum — Lehne's Pharmacotherapeutics for Advanced Practice Providers, 3rd ed.
EXAM INSTRUCTIONS
This practice exam mirrors Exam Soft format. Each question is clinical scenario-based with four answer
choices (A-D). Select the BEST answer. Correct answers and rationale are provided below each question for
self- assessment.
Total Questions Time Allotted Format Chapters
100 Questions 120 Minutes Multiple Choice (A-D) 1-10, 36-39, 41-46, 24,
35, 59-63
For educational use only | NR565 Midterm Practice Exam 2026
, WEEK 1 | Chapters 1-10 | Foundations in Pharmacology (Questions 1-
25)
1. [Prescriptive Authority] A nurse practitioner in a state with full practice authority wants to prescribe a
Schedule II controlled substance. Which of the following is required?
A. Collaboration agreement with a supervising physician
B. A valid DEA registration number
C. Approval from the state board of medicine
D. Completion of a pain management fellowship
Correct Answer: B
Rationale: Prescribing Schedule II controlled substances requires a valid DEA registration number
regardless of practice authority level. Full practice authority removes the need for physician collaboration
agreements for non-controlled prescribing.
Reference: Rosenthal, L. D., & Burchum, J. R. (2026). Lehne's pharmacotherapeutics for advanced practice providers
(3rd ed.). Elsevier.
2. [Prescription Writing] When writing a valid outpatient prescription, which element is legally required on
EVERY prescription?
A. Diagnosis code (ICD-10)
B. Patient's date of birth
C. Drug name, dose, route, frequency, and quantity
D. Insurance provider information
Correct Answer: C
Rationale: Every prescription must contain the drug name, dose, route of administration,
frequency/directions (sig), and quantity to dispense. Date of birth is best practice but not universally legally
mandated on the face of the prescription in all states.
Reference: Rosenthal, L. D., & Burchum, J. R. (2026). Lehne's pharmacotherapeutics for advanced practice providers
(3rd ed.). Elsevier.
3. [Drug Absorption] A patient with severe small bowel disease has markedly reduced intestinal surface area.
Which route of drug administration would BEST bypass this limitation?
A. Oral (PO)
B. Sublingual (SL)
C. Rectal (PR)
D. Intravenous (IV)
Correct Answer: D
Rationale: IV administration delivers drug directly into systemic circulation, completely bypassing GI
absorption. This achieves 100% bioavailability and is unaffected by intestinal surface area reductions.
Reference: Rosenthal, L. D., & Burchum, J. R. (2026). Lehne's pharmacotherapeutics for advanced practice providers
(3rd ed.). Elsevier.
4. [Drug Distribution] Which property of a drug MOST directly determines its volume of distribution (Vd)?
A. Renal clearance rate
B. Plasma protein binding and lipid solubility
C. First-pass metabolism
D. CYP enzyme affinity
Correct Answer: B
Rationale: Volume of distribution is determined largely by a drug's lipid solubility (highly lipid-soluble drugs
distribute widely into tissues) and protein binding (highly protein-bound drugs stay in the vascular
compartment, lowering Vd).
Reference: Rosenthal, L. D., & Burchum, J. R. (2026). Lehne's pharmacotherapeutics for advanced practice providers
(3rd ed.). Elsevier.
For educational use only | NR565 Midterm Practice Exam
